What is Global Long-Acting Reversible Contraception(LARC) Market?
The Global Long-Acting Reversible Contraception (LARC) Market refers to the worldwide market for contraceptive methods that provide effective birth control for an extended period without requiring user action. These methods include intrauterine devices (IUDs) and subcutaneous implants, which are designed to be long-lasting, typically ranging from three to ten years, depending on the type. LARC methods are highly effective, with failure rates of less than 1%, making them a popular choice for individuals seeking reliable and low-maintenance contraception. The market encompasses various products, manufacturers, and healthcare providers involved in the development, production, and distribution of these contraceptive methods. The increasing awareness and acceptance of LARC methods, coupled with advancements in medical technology, are driving the growth of this market globally.
Intrauterine Devices (IUCs), Subcutaneous Implant in the Global Long-Acting Reversible Contraception(LARC) Market:
Intrauterine Devices (IUDs) and subcutaneous implants are two primary types of long-acting reversible contraception (LARC) that dominate the global market. IUDs are small, T-shaped devices inserted into the uterus by a healthcare provider. They come in two main types: hormonal IUDs, which release progestin to prevent pregnancy, and copper IUDs, which use copper to create an inhospitable environment for sperm. Hormonal IUDs can last between three to seven years, while copper IUDs can be effective for up to ten years. Subcutaneous implants, on the other hand, are small, flexible rods placed under the skin of the upper arm. These implants release a steady dose of progestin to prevent ovulation and thicken cervical mucus, making it difficult for sperm to reach the egg. The most common implant, Nexplanon, is effective for up to three years. Both IUDs and implants offer several advantages, including high efficacy, low maintenance, and reversibility, making them appealing options for individuals seeking long-term contraception. The global LARC market is driven by factors such as increasing awareness of contraceptive options, government initiatives promoting family planning, and the rising demand for effective and convenient birth control methods. Additionally, advancements in medical technology and the development of new and improved LARC products are expected to further boost market growth.
Age 20~24 Years Old, Age 25-34 Years Old, Age 35~44 Years Old, Other in the Global Long-Acting Reversible Contraception(LARC) Market:
The usage of Global Long-Acting Reversible Contraception (LARC) varies across different age groups, reflecting the diverse needs and preferences of individuals at different stages of their reproductive lives. For individuals aged 20-24 years old, LARC methods are particularly appealing due to their high efficacy and low maintenance. This age group often seeks reliable contraception to prevent unintended pregnancies while focusing on education, career development, and personal growth. The convenience of not having to remember daily pills or frequent doctor visits makes LARC an attractive option for young adults. For those aged 25-34 years old, LARC usage continues to be significant as many individuals in this age group are in committed relationships or starting families. LARC methods provide a reliable means of spacing pregnancies and allowing couples to plan their families according to their preferences and circumstances. The reversibility of LARC methods is also a key factor, as it allows individuals to conceive when they are ready. For individuals aged 35-44 years old, LARC methods offer a dependable solution for those who may have completed their families or are looking for long-term contraception as they approach the end of their reproductive years. The effectiveness and low maintenance of LARC methods are particularly beneficial for this age group, as they may have busy lifestyles and multiple responsibilities. Additionally, LARC methods can be a suitable option for individuals who may have health conditions that contraindicate the use of other forms of contraception. Other age groups, including adolescents and individuals over 45 years old, also benefit from LARC methods, although their usage may be influenced by different factors such as health considerations, personal preferences, and access to healthcare services. Overall, the global LARC market caters to a wide range of age groups, providing effective and convenient contraceptive options that meet the diverse needs of individuals at different stages of their reproductive lives.
Global Long-Acting Reversible Contraception(LARC) Market Outlook:
The global Long-Acting Reversible Contraception (LARC) market was valued at US$ 1154 million in 2023 and is anticipated to reach US$ 1730.6 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030. The global pharmaceutical market was valued at 1475 billion USD in 2022 and is expected to grow at a CAGR of 5% over the next six years. In comparison, the chemical drug market is estimated to increase from 1005 billion USD in 2018 to 1094 billion USD in 2022.
| Report Metric | Details |
| Report Name | Long-Acting Reversible Contraception(LARC) Market |
| Accounted market size in 2023 | US$ 1154 million |
| Forecasted market size in 2030 | US$ 1730.6 million |
| CAGR | 6.0% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Bayer, Merck, Teva Pharmaceutical, Allergan, HRA Pharma, Eurogine, Yantai Family Planning Pharmaceutical Equipment Co., Ltd., Wuxi Tianyi Medical Equipment Co., Ltd., SMB Corporation, Shenyang Liren, Tianjin Hejie Medical Equipment Co., Ltd., Cooper Companies, AbbVie Allergan, Organon, Shanghai Dahua Pharmaceutical |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
